榮科科技(300290.SZ):股東崔萬濤質押600萬股
格隆匯12月23日丨榮科科技(300290.SZ)公佈,公司於今日接到公司持股5%以上股東崔萬濤的通知,因個人資金需求,崔萬濤將其持有的公司股票600萬股流通股質押給了黃燕燕、徐雅網。相關手續已於2019年12月20日通過中國證券登記結算有限公司辦理。
截至公告披露日,崔萬濤持有公司股票3567.2573萬股,佔公司總股本的6.44%。此次股票質押後,崔萬濤累計質押公司股票1030萬股,佔公司總股本的1.86%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.